135 related articles for article (PubMed ID: 28163135)
1. A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats.
Jiang Y; Milavetz G; James MO; An G
J Pharm Sci; 2017 May; 106(5):1396-1404. PubMed ID: 28163135
[TBL] [Abstract][Full Text] [Related]
2. Model Informed Dose Optimization of Dichloroacetate for the Treatment of Congenital Lactic Acidosis in Children.
Mangal N; James MO; Stacpoole PW; Schmidt S
J Clin Pharmacol; 2018 Feb; 58(2):212-220. PubMed ID: 28914978
[TBL] [Abstract][Full Text] [Related]
3. Effects of Multiple Doses of Dichloroacetate on GSTZ1 Expression and Activity in Liver and Extrahepatic Tissues of Young and Adult Rats.
Squirewell EJ; Smeltz MG; Rowland-Faux L; Horne LP; Stacpoole PW; James MO
Drug Metab Dispos; 2020 Nov; 48(11):1217-1223. PubMed ID: 32873593
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Glutathione Transferase Zeta 1 Is Inactivated More Rapidly by Dichloroacetate than the Cytosolic Enzyme in Adult and Juvenile Rat Liver.
Smeltz MG; Hu Z; Zhong G; Jahn SC; Rowland-Faux L; Horne LP; Stacpoole PW; James MO
Chem Res Toxicol; 2019 Oct; 32(10):2042-2052. PubMed ID: 31524376
[TBL] [Abstract][Full Text] [Related]
5. Chloride and other anions inhibit dichloroacetate-induced inactivation of human liver GSTZ1 in a haplotype-dependent manner.
Zhong G; Li W; Gu Y; Langaee T; Stacpoole PW; James MO
Chem Biol Interact; 2014 May; 215():33-9. PubMed ID: 24632415
[TBL] [Abstract][Full Text] [Related]
6. Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats.
Saghir SA; Schultz IR
Environ Health Perspect; 2002 Aug; 110(8):757-63. PubMed ID: 12153755
[TBL] [Abstract][Full Text] [Related]
7. Exposure of Rats to Multiple Oral Doses of Dichloroacetate Results in Upregulation of Hepatic Glutathione Transferases and NAD(P)H Dehydrogenase [Quinone] 1.
Squirewell EJ; Mareus R; Horne LP; Stacpoole PW; James MO
Drug Metab Dispos; 2020 Nov; 48(11):1224-1230. PubMed ID: 32873592
[TBL] [Abstract][Full Text] [Related]
8. A quantitative description of suicide inhibition of dichloroacetic acid in rats and mice.
Keys DA; Schultz IR; Mahle DA; Fisher JW
Toxicol Sci; 2004 Dec; 82(2):381-93. PubMed ID: 15375292
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.
James MO; Jahn SC; Zhong G; Smeltz MG; Hu Z; Stacpoole PW
Pharmacol Ther; 2017 Feb; 170():166-180. PubMed ID: 27771434
[TBL] [Abstract][Full Text] [Related]
10.
Tian DD; Bennett SK; Coupland LA; Forwood K; Lwin Y; Pooryousef N; Tea I; Truong TT; Neeman T; Crispin P; D'Rozario J; Blackburn AC
Pharmacol Res Perspect; 2019 Dec; 7(6):e00526. PubMed ID: 31624634
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic considerations with dichloroacetate dosing.
James MO; Stacpoole PW
Pharmacogenomics; 2016 May; 17(7):743-53. PubMed ID: 27143230
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking alpha-haloalkanoic acids.
Anderson WB; Board PG; Gargano B; Anders MW
Chem Res Toxicol; 1999 Dec; 12(12):1144-9. PubMed ID: 10604862
[TBL] [Abstract][Full Text] [Related]
13. Personalized Dosing of Dichloroacetate Using GSTZ1 Clinical Genotyping Assay.
Langaee T; Wagner R; Horne LP; Lawson LA; Becker C; Shahin M; Starostik P; Stacpoole PW
Genet Test Mol Biomarkers; 2018 Apr; 22(4):266-269. PubMed ID: 29641284
[TBL] [Abstract][Full Text] [Related]
14. Haplotype variations in glutathione transferase zeta 1 influence the kinetics and dynamics of chronic dichloroacetate in children.
Shroads AL; Coats BS; McDonough CW; Langaee T; Stacpoole PW
J Clin Pharmacol; 2015 Jan; 55(1):50-5. PubMed ID: 25079374
[TBL] [Abstract][Full Text] [Related]
15. Perturbation of maleylacetoacetic acid metabolism in rats with dichloroacetic Acid-induced glutathione transferase zeta deficiency.
Lantum HB; Cornejo J; Pierce RH; Anders MW
Toxicol Sci; 2003 Jul; 74(1):192-202. PubMed ID: 12730618
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity of chlorofluoroacetic acid in rats.
Lantum HB; Baggs RB; Krenitsky DM; Anders MW
Toxicol Sci; 2002 Dec; 70(2):261-8. PubMed ID: 12441371
[TBL] [Abstract][Full Text] [Related]
17. Dichloroacetate toxicokinetics and disruption of tyrosine catabolism in B6C3F1 mice: dose-response relationships and age as a modifying factor.
Schultz IR; Merdink JL; Gonzalez-Leon A; Bull RJ
Toxicology; 2002 May; 173(3):229-47. PubMed ID: 11960676
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of oral dichloroacetate in dogs.
Maisenbacher HW; Shroads AL; Zhong G; Daigle AD; Abdelmalak MM; Samper IS; Mincey BD; James MO; Stacpoole PW
J Biochem Mol Toxicol; 2013 Dec; 27(12):522-5. PubMed ID: 24038869
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of dichloroacetic acid kinetics in human--a physiologically based pharmacokinetic modeling investigation.
Li T; Schultz I; Keys DA; Campbell JL; Fisher JW
Toxicology; 2008 Mar; 245(1-2):35-48. PubMed ID: 18242812
[TBL] [Abstract][Full Text] [Related]
20. The influence of human GSTZ1 gene haplotype variations on GSTZ1 expression.
Langaee TY; Zhong G; Li W; Hamadeh I; Solayman MH; McDonough CW; Stacpoole PW; James MO
Pharmacogenet Genomics; 2015 May; 25(5):239-45. PubMed ID: 25738370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
